Interplay Between the Human Microbiome and Diseases
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 October 2025 | Viewed by 1215
Special Issue Editors
Interests: biomarkers; stroke; antiplatelet therapy; personalized medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The human microbiome has a great impact on our health throughout our lives. The human gut microbiota is the primary source of human microbial populations, contributing considerably to both positive and negative outcomes. The impact of gut microbial population has been studied intensively over the last two decades. The gut microbiota of healthy individuals differs from that of those affected by disease and the deviation in the composition can lead to different disorders. The dysbiosis of the microbiota with respect to different life-threatening diseases such as cancer, cardiovascular disease, bowel inflammatory disease and difficult-to-treat bacterial infections is of great interest. Studies support not only the discovery and understanding of the link between certain diseases and the microbiome, but also the possibility of modifying it through dietary changes, lifestyle changes, the use of special microbe cocktails or fecal microbiota transplantation. Research on the human microbiome and its role in treating diseases is welcomed for publication in this Special Issue.
Prof. Dr. Tihamer Molnar
Dr. Zoltán Péterfi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- microbiome
- metagenome
- gastrointestinal tract
- skin
- seminal fluid
- lung
- saliva
- oral mucosa
- conjunctiva
- dysbiosis
- fecal microbiota transplantation
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
